Details for New Drug Application (NDA): 087768
✉ Email this page to a colleague
The generic ingredient in BILIVIST is ipodate sodium. There is one drug master file entry for this compound. Additional details are available on the ipodate sodium profile page.
Summary for 087768
Tradename: | BILIVIST |
Applicant: | Bayer Hlthcare |
Ingredient: | ipodate sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
Approval Date: | Aug 11, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription